HomepageMedicineEmergent BioSolutions Names Joseph C. Papa As CEO Medicine Emergent BioSolutions Names Joseph C. Papa As CEO admin Posted on February 22, 2024 Papa will take over the over effective immediately. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostL&T bags order for residential towers in Thane; stock trades flat Next PostWas Diesel the Most Democratic Fashion Show Ever? You Might Also Like Medicine 79% of Respondents Admit to Neglecting Health Needs During the Holiday Season admin December 22, 2023 Medicine FDA Approves Expanded Indication for Dovato to Include Adolescent Patients with HIV admin April 9, 2024 Medicine FDA Grants Accelerated Approval to Adaptimmune Therapeutics’ Tecelra for Adults with Synovial Sarcoma Who Have Undergone Prior Chemotherapy admin August 3, 2024 Medicine FDA Grants Breakthrough Therapy Designation to Biogen’s Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplants admin October 9, 2024
Medicine 79% of Respondents Admit to Neglecting Health Needs During the Holiday Season admin December 22, 2023
Medicine FDA Approves Expanded Indication for Dovato to Include Adolescent Patients with HIV admin April 9, 2024
Medicine FDA Grants Accelerated Approval to Adaptimmune Therapeutics’ Tecelra for Adults with Synovial Sarcoma Who Have Undergone Prior Chemotherapy admin August 3, 2024
Medicine FDA Grants Breakthrough Therapy Designation to Biogen’s Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplants admin October 9, 2024